Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
Add more filters










Publication year range
2.
Mol Vis ; 26: 540-562, 2020.
Article in English | MEDLINE | ID: mdl-32818017

ABSTRACT

Purpose: Previous research in our laboratory indicated that prothrombin and other coagulation enzymes required to activate prothrombin to thrombin are synthesized by the cornea and that apoptotic human corneal stromal cells can provide a surface for prothrombin activation through the intrinsic and extrinsic coagulation pathways. The purpose of the work reported here is to study the role of thrombin activity in the regulation of matricellular protein Cyr61 (CCN1) produced by wounded phenotype human corneal stromal fibroblasts and myofibroblasts. Methods: Stromal cells from human donor corneas were converted to defined wounded phenotype fibroblasts and myofibroblasts with fetal bovine serum, followed by basic fibroblast growth factor (bFGF) and transforming growth factor beta-1 (TGFß-1), respectively, and stimulated with varying concentrations (0-10.0 units (U)/ml) of thrombin from 1-7 h. Cyr61 transcript levels were determined using reverse transcriptase-PCR (RT-PCR) and quantitative PCR (qPCR) while protein forms were analyzed using western blot data. Protease activities were characterized via protease class-specific inhibitors and western blot analysis. Thrombin activity was quantified using the fluorogenic peptide Phe-Pro-Arg-AFC. Protease-activated receptor (PAR) agonist peptides-1 and -4 were used to determine whether cells increased Cyr61 through PAR signaling pathways. The PAR-1 antagonist SCH 79797 was used to block the thrombin cleavage of the receptor. PCR data were analyzed using MxPro software and western blot data were analyzed using Image Lab™ and Image J software. Student t test and one- and two-way ANOVA (with or without ranking, depending on sample distribution), together with Dunnett's test or Tukey comparison tests for post-hoc analysis, were used to determine statistical significance.Results: Full-length Cyr61 is expressed by human corneal stromal fibroblasts and myofibroblasts and is significantly upregulated by active thrombin stimulation at the message (p<0.03) and protein (p<0.03) levels for fibroblasts and myofibroblasts. Inhibition by the allosteric thrombin-specific inhibitor hirudin prevented the thrombin-associated increase in the Cyr61 protein expression, indicating that the proteolytic activity of thrombin is required for the increase of the Cyr61 protein level. PAR-1 agonist stimulation of fibroblasts and myofibroblasts significantly increased cell-associated Cyr61 protein levels (p<0.04), and PAR-1 antagonist SCH 79797 significantly inhibited the thrombin stimulated increase of Cyr61 in fibroblasts but not in myofibroblasts. In the fibroblast and myofibroblast conditioned media, Cyr61 was detected as the full-length 40 kDa protein in the absence of thrombin, and mainly at 24 kDa in the presence of thrombin at ≥0.5 U/ml, using an antibody directed toward the internal linker region between the von Willebrand factor type C and thrombospondin type-1 domains. Although known to undergo alternative splicing, Cyr61 that is synthesized by corneal fibroblasts and myofibroblasts is not alternatively spliced in response to thrombin stimulation nor is Cyr61 directly cleaved by thrombin to generate its 24 kDa form; instead, Cyr61 is proteolytically processed into 24 kDa N- and 16 kDa C-terminal fragments by a thrombin activated leupeptin-sensitive protease present in conditioned media with activity distinct from the proteolytic activity of thrombin. Conclusions: In cultured human corneal stromal fibroblasts and myofibroblasts, thrombin regulates Cyr61 through two mechanisms: 1) thrombin increases the Cyr61 expression at the message and protein levels, and 2) thrombin increases the activation of a leupeptin-sensitive protease that stimulates the cleavage of Cyr61 into N- and C-terminal domain populations in or near the thrombospondin type-1 domain. Generation of Cyr61 peptides during corneal injury stimulation may reveal additional functions of the protein, which modulate corneal wound healing activities or decrease activities of the full-length Cyr61 form.


Subject(s)
Cysteine-Rich Protein 61/genetics , Fibroblasts/drug effects , Myofibroblasts/drug effects , Receptors, Proteinase-Activated/genetics , Stromal Cells/drug effects , Thrombin/pharmacology , Alternative Splicing , Cell Differentiation , Corneal Stroma/cytology , Corneal Stroma/metabolism , Culture Media, Conditioned/pharmacology , Cysteine-Rich Protein 61/antagonists & inhibitors , Cysteine-Rich Protein 61/metabolism , Fibroblast Growth Factor 2/pharmacology , Fibroblasts/cytology , Fibroblasts/metabolism , Hirudins/pharmacology , Humans , Leupeptins/pharmacology , Myofibroblasts/cytology , Myofibroblasts/metabolism , Primary Cell Culture , Proteolysis , Pyrroles/pharmacology , Quinazolines/pharmacology , RNA, Messenger/antagonists & inhibitors , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Proteinase-Activated/metabolism , Signal Transduction , Stromal Cells/cytology , Stromal Cells/metabolism , Thrombin/metabolism , Transforming Growth Factor beta1/pharmacology
3.
Invest Ophthalmol Vis Sci ; 55(12): 7697-708, 2014 Oct 30.
Article in English | MEDLINE | ID: mdl-25358730

ABSTRACT

PURPOSE: Insulin-like growth factor 2 receptor (IGF2R) associates with ligands that influence wound healing outcomes. However, the expression pattern of IGF2R and its role in the cornea is unknown. METHODS: Human keratocytes were isolated from donor corneas. Fibroblasts (fibroblast growth factor 2 [FGF2]-treated) or myofibroblasts (TGF-ß1-treated) were analyzed for IGF2R and α-smooth muscle actin (α-SMA) expression by Western blotting and immunolocalization. Mouse corneas were wounded in vivo and porcine corneas ex vivo. The IGF2R and α-SMA protein expression were visualized and quantified by immunohistochemistry. The IGF2R gene expression in human corneal fibroblasts was knocked-down with targeted lentiviral shRNA. RESULTS: The IGF2R is expressed in epithelial and stromal cells of normal human, mouse, and porcine corneas. The IGF2R increases (11.2 ± 0.4-fold) in the epithelial and (11.7 ± 0.9-fold) stromal layers of in vivo wounded mouse corneas. Double-staining with α-SMA- and IGF2R-specific antibodies reveals that IGF2R protein expression is increased in stromal myofibroblasts in the wounded cornea relative to keratocytes in the normal cornea (11.2 ± 0.8-fold). Human primary stromal keratocytes incubated with FGF2 or TGF-ß1 in vitro demonstrate increased expression (2.0 ± 0.4-fold) of IGF2R in myofibroblasts relative to fibroblasts. Conversion of IGF2R shRNA-lentiviral particle transduced corneal fibroblasts to myofibroblasts reveals a dependence on IGF2R expression, as only 40% ± 10% of cells transduced converted to myofibroblasts compared to 86% ± 3% in control cells. CONCLUSIONS: The IGF2R protein expression is increased during corneal wound healing and IGF2R regulates human corneal fibroblast to myofibroblast differentiation.


Subject(s)
Corneal Keratocytes/metabolism , Insulin-Like Growth Factor II/metabolism , Wound Healing/physiology , Actins/metabolism , Animals , Blotting, Western , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cells, Cultured , Corneal Keratocytes/cytology , Corneal Keratocytes/drug effects , Disease Models, Animal , Gene Expression Regulation/physiology , Humans , Immunohistochemistry , Insulin-Like Growth Factor II/genetics , Mice , Myofibroblasts/drug effects , Myofibroblasts/metabolism , Swine , Transforming Growth Factor beta/pharmacology
4.
PLoS One ; 7(3): e33915, 2012.
Article in English | MEDLINE | ID: mdl-22470492

ABSTRACT

Myofibroblasts (Mfs) that persist in a healing wound promote extracellular matrix (ECM) accumulation and excessive tissue contraction. Increased levels of integrin αvß5 promote the Mf phenotype and other fibrotic markers. Previously we reported that maintaining uPA (urokinase plasminogen activator) bound to its cell-surface receptor, uPAR prevented TGFß-induced Mf differentiation. We now demonstrate that uPA/uPAR controls integrin ß5 protein levels and in turn, the Mf phenotype. When cell-surface uPA was increased, integrin ß5 levels were reduced (61%). In contrast, when uPA/uPAR was silenced, integrin ß5 total and cell-surface levels were increased (2-4 fold). Integrin ß5 accumulation resulted from a significant decrease in ß5 ubiquitination leading to a decrease in the degradation rate of internalized ß5. uPA-silencing also induced α-SMA stress fiber organization in cells that were seeded on collagen, increased cell area (1.7 fold), and increased integrin ß1 binding to the collagen matrix, with reduced activation of ß1. Elevated cell-surface integrin ß5 was necessary for these changes after uPA-silencing since blocking αvß5 function reversed these effects. Our data support a novel mechanism by which downregulation of uPA/uPAR results in increased integrin αvß5 cell-surface protein levels that regulate the activity of ß1 integrins, promoting characteristics of the persistent Mf.


Subject(s)
Receptors, Urokinase Plasminogen Activator/metabolism , Receptors, Vitronectin/metabolism , Urokinase-Type Plasminogen Activator/metabolism , Actins/metabolism , Antibodies/immunology , Cells, Cultured , Collagen/metabolism , Humans , Integrin beta1/genetics , Integrin beta1/metabolism , Myofibroblasts/metabolism , RNA Interference , RNA, Small Interfering/metabolism , Receptors, Urokinase Plasminogen Activator/antagonists & inhibitors , Receptors, Urokinase Plasminogen Activator/genetics , Receptors, Vitronectin/immunology , Transforming Growth Factor beta/metabolism , Ubiquitination , Urokinase-Type Plasminogen Activator/antagonists & inhibitors , Urokinase-Type Plasminogen Activator/genetics
5.
Exp Eye Res ; 93(5): 618-27, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21810423

ABSTRACT

Maspin, an inhibitor of cell migration and a stimulator of adhesion of cells to the ECM, is synthesized and released by corneal keratocytes into the extracellular matrix. When the cornea is wounded, the quiescent stromal keratocytes underlying the wound undergo apoptosis and cells adjacent to this apoptotic area convert to fibroblasts or myofibroblasts. This study explores the effect of extracellular maspin on the plasminogen-plasminogen activator system of corneal stromal cells following wounding. Treatment of corneal fibroblasts and myofibroblasts with r-maspin increased extracellular but not cell-associated tissue-type plasminogen activator (tPA), urinary-type plasminogen activator (uPA) or plasminogen activator inhibitor-1 (PAI-1). Despite the extracellular increase in PAI-1, the net effect of maspin treatment was an increase in plasminogen activation. At physiological levels, maspin did not alter uPA or tPA mRNA levels, in these cells. The increase in pro and active uPA was due to decreased clearance in the presence of maspin for myofibroblasts but not for fibroblasts. The clearance of pro and active tPA was normal in fibroblasts indicating different mechanisms for the increase of these homologous enzymes in the two cell types. Increased generation of plasmin by maspin treated corneal stromal fibroblasts and myofibroblasts led to conversion of plasminogen to active plasmin degradation products and angiostatin-like molecules. This study suggests that extracellular maspin increased pro and active uPA and tPA released by corneal fibroblasts and myofibroblasts on the short time scale of 1-4 h, but by 24 h there was no increase over the levels produced without maspin. This augmentation of plasminogen activator activity increases plasmin activation and angiostatin generation. It further indicates that the effect of maspin on uPA and tPA levels is cell type dependent.


Subject(s)
Corneal Stroma/cytology , Fibroblasts/drug effects , Myofibroblasts/drug effects , Plasminogen Activators/metabolism , Serine Proteinase Inhibitors/pharmacology , Serpins/pharmacology , Angiostatins/metabolism , Blotting, Western , Cells, Cultured , Cycloheximide/pharmacology , Fibroblasts/metabolism , Humans , Myofibroblasts/metabolism , Plasminogen Activator Inhibitor 1/metabolism , Real-Time Polymerase Chain Reaction , Recombinant Proteins/pharmacology , Tissue Plasminogen Activator/metabolism , Urokinase-Type Plasminogen Activator/metabolism , Wound Healing
6.
J Biol Chem ; 286(28): 24599-607, 2011 Jul 15.
Article in English | MEDLINE | ID: mdl-21606500

ABSTRACT

Maspin is a non-inhibitory serine protease inhibitor (serpin) that influences many cellular functions including adhesion, migration, and invasion. The underlying molecular mechanisms that facilitate these actions are still being elucidated. In this study we determined the mechanism by which maspin mediates increased MCF10A cell adhesion. Utilizing competition peptides and mutation analyses, we discovered two unique regions (amino acid residues 190-202 and 260-275) involved in facilitating the increased adhesion function of maspin. In addition, we demonstrate that the urokinase-type plasminogen activator (uPA)/uPA receptor (uPAR) complex is required for the localization and adhesion function of maspin. Finally, we showed that maspin, uPAR, and ß1 integrin co-immunoprecipitate, suggesting a novel maspin-uPA-uPAR-ß1 integrin mega-complex that regulates mammary epithelial cell adhesion.


Subject(s)
Epithelial Cells/metabolism , Integrin beta1/metabolism , Multiprotein Complexes/metabolism , Receptors, Urokinase Plasminogen Activator/metabolism , Serpins/metabolism , Cell Adhesion/physiology , Cell Line, Transformed , Epithelial Cells/cytology , Humans , Integrin beta1/genetics , Multiprotein Complexes/genetics , Receptors, Urokinase Plasminogen Activator/genetics , Serpins/genetics
7.
Proteomics ; 11(8): 1382-90, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21365746

ABSTRACT

Maspin, a 42-kDa non-classical serine protease inhibitor (serpin), is expressed by epithelial cells of various tissues including the cornea. The protein localizes to the nucleus and cytosol, and is present in the extracellular space. While extracellular maspin regulates corneal stromal fibroblast adhesion and inhibits angiogenesis during wound healing in the cornea, the molecular mechanism of its extracellular functions is unclear. We hypothesized that identifying post-translational modifications of maspin, such as phosphorylation, may help decipher its mode of action. The focus of this study was on the identification of phosphorylation sites on extracellular maspin, since the extracellular form of the molecule is implicated in several functions. Multi-stage fragmentation MS was used to identify sites of phosphorylation on extracellular corneal epithelial cell maspin. A total of eight serine and threonine phosphorylation sites (Thr50, Ser97, Thr118, Thr157, Ser240, Ser298, Thr310 and Ser316) were identified on the extracellular forms of the molecule. Phosphorylation of tyrosine residues was not detected on extracellular maspin from corneal epithelial cell, in contrast to breast epithelial cells. This study provides the basis for further investigation into the functional role of phosphorylation of corneal epithelial maspin.


Subject(s)
Epithelium, Corneal/chemistry , Protein Processing, Post-Translational , Serpins/analysis , Blotting, Western , Cell Line , Epithelium, Corneal/metabolism , Extracellular Space/chemistry , Extracellular Space/metabolism , Humans , Immunoprecipitation , Isoelectric Focusing , Phosphorylation , Serpins/genetics , Serpins/metabolism , Wound Healing/physiology
8.
J Bacteriol ; 192(6): 1498-510, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20061478

ABSTRACT

Currently, one-third of the world's population is believed to be latently infected with Mycobacterium tuberculosis. The mechanisms by which M. tuberculosis establishes latent infection remain largely undefined. mprAB encodes a two-component signal transduction system required by M. tuberculosis for aspects of persistent infection. MprAB regulates a large and diverse group of genetic determinants in response to membrane stress, including the extracytoplasmic function (ECF) sigma factor sigE and the HtrA-like serine protease pepD. Recent studies have demonstrated that PepD functions as both a protease and chaperone in vitro. In addition, inactivation of pepD alters the virulence of M. tuberculosis in a mouse model system of infection. Here, we demonstrate that PepD plays an important role in the stress response network of Mycobacterium mediated through MprAB and SigE. In particular, we demonstrate that the protease activity of PepD requires the PDZ domain, in addition to the catalytic serine at position 317. pepD expression initiates from at least three promoters in M. tuberculosis, including one that is regulated by SigE and is located upstream of the mprA coding sequence. Deletion of pepD or mprAB in Mycobacterium smegmatis and M. tuberculosis alters the stress response phenotypes of these strains, including increasing sensitivity to SDS and cell wall antibiotics and upregulating the expression of stress-responsive determinants, including sigE. Taking these data together, we hypothesize that PepD utilizes its PDZ domain to recognize and process misfolded proteins at the cell membrane, leading to activation of the MprAB and SigE signaling pathways and subsequent establishment of a positive feedback loop that facilitates bacterial adaptation.


Subject(s)
Bacterial Proteins/metabolism , Gene Expression Regulation, Bacterial/physiology , Mycobacterium tuberculosis/metabolism , Signal Transduction/physiology , Stress, Physiological/physiology , Animals , Bacterial Proteins/genetics , Gene Expression Profiling , Oligonucleotide Array Sequence Analysis , Promoter Regions, Genetic , Transcription, Genetic
9.
Biochemistry ; 49(3): 635-44, 2010 Jan 26.
Article in English | MEDLINE | ID: mdl-20028034

ABSTRACT

The 300 kDa cation-independent mannose 6-phosphate receptor (CI-MPR) is a multifunctional protein that binds diverse intracellular and extracellular ligands with high affinity. The CI-MPR is a receptor for plasminogen, and this interaction can be inhibited by lysine analogues. To characterize the molecular basis for this interaction, surface plasmon resonance (SPR) analyses were performed using truncated forms of the CI-MPR and plasminogen. The results show that the N-terminal region of the CI-MPR containing domains 1 and 2, but not domain 1 alone, of the receptor's 15-domain extracytoplasmic region binds plasminogen (K(d) = 5 +/- 1 nM) with an affinity similar to that of the full-length receptor (K(d) = 20 +/- 6 nM). In addition to its C-terminal serine protease domain, plasminogen contains lysine binding sites (LBS), which are located within each of its five kringle domains, except kringle 3. We show that kringles 1-4, but not kringles 1-3, bind the CI-MPR, indicating an essential role for the LBS in kringle 4 of plasminogen. To identify the lysine residue(s) of the CI-MPR that serve(s) as an essential determinant for recognition by the LBS of plasminogen, site-directed mutagenesis studies were carried out using a construct encoding the N-terminal three domains of the CI-MPR (Dom1-3His) which contains both a mannose 6-phosphate (Man-6-P) and plasminogen binding site. The results demonstrate two lysine residues (Lys53 located in domain 1 and Lys125 located in the loop connecting domains 1 and 2) of the CI-MPR are key determinants for plasminogen binding but are not required for Man-6-P binding.


Subject(s)
Plasminogen/chemistry , Plasminogen/metabolism , Receptor, IGF Type 2/chemistry , Receptor, IGF Type 2/metabolism , Animals , Binding Sites , Cations/chemistry , Cattle , Humans , Kinetics , Kringles , Ligands , Lysine/genetics , Lysine/metabolism , Plasminogen/genetics , Substrate Specificity , Surface Plasmon Resonance
10.
Exp Eye Res ; 86(4): 586-600, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18291368

ABSTRACT

Maspin, a 42 kDa non-classical serpin (serine protease inhibitor) that controls cell migration and invasion, is mainly expressed by epithelial-derived cells but is also expressed in corneal stromal keratocytes. Upon culture of stromal keratocytes in the presence of FBS, maspin is down-regulated to nearly undetectable levels by passage two. DNA methylation is one of several processes that controls gene expression during cell differentiation, development, genetic imprinting, and carcinogenesis but has not been studied in corneal stromal cells. The purpose of this study was to determine whether DNA methylation of the maspin promoter and histone H3 dimethylation is involved in the mechanism of down-regulation of maspin synthesis in human corneal stromal fibroblasts and myofibroblasts. Human donor corneal stroma cells were immediately placed into serum-free defined medium or cultured in the presence of FBS and passed into serum-free medium or medium containing FBS or FGF-2 to induce the fibroblast phenotype or TGF-beta1 for the myofibroblast phenotype. These cell types are found in wounded corneas. The cells were used to prepare RNA for semi-quantitative or quantitative RT-PCR or to extract protein for Western analysis. In addition, P4 FBS cultured fibroblasts were treated with the DNA demethylating agent, 5-aza-2'-deoxycytidine (5-Aza-dC), and the histone deacetylase inhibitor, trichostatin A (TSA). Cells with and without treatment were harvested and assayed for DNA methylation using sodium bisulfite sequencing. The methylation state of histone H3 associated with the maspin gene in the P4 fibroblast cells was determined using a ChIP assay. Freshly harvested corneal stromal cells expressed maspin but upon phenotypic differentiation, maspin mRNA and protein were dramatically down-regulated. Sodium bisulfite sequencing revealed that the maspin promoter in the freshly isolated stromal keratocytes was hypomethylated while both the P0 stromal cells and the P1 cells cultured in the presence of serum-free defined medium, FGF-2 and TGF-beta1 were hypermethylated. Down-regulation of maspin synthesis was also associated with histone H3 dimethylation at lysine 9. Both maspin mRNA and protein were re-expressed at low levels with 5-Aza-dC but not TSA treatment. Addition of TSA to 5-Aza-dC treated cells did not increase maspin expression. Treatment with 5-Aza-dC did not significantly alter demethylation of the maspin promoter but did demethylate histone H3. These results show maspin promoter hypermethylation and histone methylation occur with down-regulation of maspin synthesis in corneal stromal cells and suggest regulation of genes upon conversion of keratocytes to wound healing fibroblasts can involve promoter and histone methylation.


Subject(s)
Corneal Stroma/metabolism , Eye Proteins/biosynthesis , Fibroblasts/cytology , Gene Silencing , Serpins/biosynthesis , Azacitidine/analogs & derivatives , Azacitidine/pharmacology , Base Sequence , Blotting, Western/methods , Cell Differentiation/genetics , Cell Differentiation/physiology , Cells, Cultured , Corneal Stroma/cytology , DNA Methylation , DNA Modification Methylases/antagonists & inhibitors , Decitabine , Down-Regulation , Enzyme Inhibitors/pharmacology , Epigenesis, Genetic , Eye Proteins/genetics , Humans , Hydroxamic Acids/pharmacology , Molecular Sequence Data , Promoter Regions, Genetic/genetics , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction/methods , Serpins/genetics
11.
Mol Biol Cell ; 18(7): 2716-27, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17507651

ABSTRACT

Fibroblasts migrate into and repopulate connective tissue wounds. At the wound edge, fibroblasts differentiate into myofibroblasts, and they promote wound closure. Regulated fibroblast-to-myofibroblast differentiation is critical for regenerative healing. Previous studies have focused on the role in fibroblasts of urokinase plasmingen activator/urokinase plasmingen activator receptor (uPA/uPAR), an extracellular protease system that promotes matrix remodeling, growth factor activation, and cell migration. Whereas fibroblasts have substantial uPA activity and uPAR expression, we discovered that cultured myofibroblasts eventually lost cell surface uPA/uPAR. This led us to investigate the relevance of uPA/uPAR activity to myofibroblast differentiation. We found that fibroblasts expressed increased amounts of full-length cell surface uPAR (D1D2D3) compared with myofibroblasts, which had reduced expression of D1D2D3 but increased expression of the truncated form of uPAR (D2D3) on their cell surface. Retaining full-length uPAR was found to be essential for regulating myofibroblast differentiation, because 1) protease inhibitors that prevented uPAR cleavage also prevented myofibroblast differentiation, and 2) overexpression of cDNA for a noncleavable form of uPAR inhibited myofibroblast differentiation. These data support a novel hypothesis that maintaining full-length uPAR on the cell surface regulates the fibroblast to myofibroblast transition and that down-regulation of uPAR is necessary for myofibroblast differentiation.


Subject(s)
Cell Differentiation , Fibroblasts/cytology , Myoblasts/cytology , Protein Processing, Post-Translational , Receptors, Cell Surface/metabolism , Actins/metabolism , Cell Differentiation/drug effects , Cornea/cytology , Cornea/drug effects , Fibroblast Growth Factor 2/pharmacology , Fibroblasts/drug effects , Fibroblasts/metabolism , Hepatocytes/cytology , Hepatocytes/drug effects , Hepatocytes/metabolism , Humans , Lung/cytology , Lung/drug effects , Lung/metabolism , Myoblasts/drug effects , Oligopeptides/pharmacology , Plasminogen Activator Inhibitor 1/metabolism , Plasminogen Activators/metabolism , Protein Processing, Post-Translational/drug effects , Receptors, Urokinase Plasminogen Activator , Stress Fibers/drug effects , Sulfones/pharmacology , Transforming Growth Factor beta1/pharmacology , Urokinase-Type Plasminogen Activator/metabolism
12.
Invest Ophthalmol Vis Sci ; 48(1): 134-43, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17197526

ABSTRACT

PURPOSE: Two major functions of thrombin observed in the cornea are activation of thrombin-sensitive, proteinase-activated receptors and cleavage of fibrinogen to fibrin. The purpose of this study was to determine whether the normal human cornea itself is competent to convert prothrombin to thrombin and synthesizes the mRNA for the proteins required. METHODS: Human corneas were processed for immunolocalization studies or separated into epithelial, stromal, and endothelial layers for proteins and RNA isolation. The protein extracts were used for Western blots, prothrombin time, and activated partial thromboplastin time assays and fibrinopeptide A generation tests. RNA was used for RT-PCR. Apoptosis of cultured human corneal cells was induced with sodium nitroprusside or camptothecin and activation of prothrombin tested. RESULTS: Prothrombin and its mRNA were present in all three layers of human donor cornea. It was found to be associated with the cells and the extracellular matrix at similar levels across the cornea. With corneal stromal extracts, activation of either the intrinsic or extrinsic coagulation pathways resulted in thrombin activation and fibrin formation with fibrinopeptide A release. Detection of key components of the coagulation cascades confirmed noninjured human corneas contain factors required for prothrombin activation. In addition, mRNAs for representative factors and inhibitors were detected by RT-PCR and confirmed by sequencing. Apoptotic corneal stromal cells provide a surface for prothrombin activation. CONCLUSIONS: These studies suggest that the normal avascular human cornea contains and synthesizes the components required for thrombin generation and that this process does not depend on a breech in the limbal vascular endothelium.


Subject(s)
Blood Coagulation Factors/physiology , Cornea/physiology , Prothrombin/metabolism , Thrombin/biosynthesis , Blotting, Western , Camptothecin/pharmacology , Capillary Permeability , Cells, Cultured , Corneal Stroma/drug effects , Corneal Stroma/metabolism , Corneal Stroma/pathology , Endothelium, Vascular/metabolism , Enzyme Inhibitors/pharmacology , Enzyme-Linked Immunosorbent Assay , Epithelium, Corneal/drug effects , Epithelium, Corneal/metabolism , Epithelium, Corneal/pathology , Fibrinopeptide A/metabolism , Humans , Immunoenzyme Techniques , Limbus Corneae/blood supply , Nitroprusside/pharmacology , Partial Thromboplastin Time , Prothrombin/genetics , Prothrombin Time , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction
13.
Curr Eye Res ; 30(12): 1097-103, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16354623

ABSTRACT

PURPOSE: To determine whether the cornea contains and expresses, at the gene level, the major plasmin inhibitor alpha2-antiplasmin. METHODS: Corneal sections were immunostained for alpha2-antiplasmin. Extracts of human corneal stroma, epithelium, and endothelium were subjected to immunodot blot and Western blot analysis. Total RNA and alpha2-antiplasmin specific primers were used for RT-PCR. The cDNA was sequenced. RESULTS: Alpha2-antiplasmin was observed in all three corneal layers by immunolocalization and Western blots. The major alpha2-antiplasmin form observed in most extracts was the 70-kDa form. Total alpha2-antiplasmin was present at 0.119 +/- 0.014 microg/epithelium (n = 10) and 1.45 +/- 0.47 microg/stroma (n = 10). Alpha2-antiplasmin mRNA was detected in epithelial and stromal extracts and cultured human corneal stromal cells. The sequences of the PCR products were identical to that for human alpha2-antiplasmin. CONCLUSIONS: Alpha2-antiplasmin and its mRNA are present in the cornea and may serve to regulate corneal plasmin activity.


Subject(s)
Antifibrinolytic Agents/metabolism , Corneal Stroma/metabolism , Endothelium, Corneal/metabolism , Epithelium, Corneal/metabolism , alpha-2-Antiplasmin/metabolism , Adolescent , Adult , Aged , Aged, 80 and over , Base Sequence , Blotting, Western , Humans , Immunoblotting , Immunoenzyme Techniques , Middle Aged , Molecular Sequence Data , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , alpha-2-Antiplasmin/genetics
14.
Mol Vis ; 11: 859-68, 2005 Oct 20.
Article in English | MEDLINE | ID: mdl-16270025

ABSTRACT

PURPOSE: Maintenance of avascularity of the normal cornea and control of neovascularization during wound healing depend on a balance of angiogenic and antiangiogenic factors. The purpose of this paper is to determine the ability of corneal cells to convert plasminogen to angiostatins and to compare these products with those made by intact corneas. METHODS: RT-PCR was performed using plasminogen specific primers and the generated cDNA was sequenced. The proteins in corneal extracts, cornea conditioned medium, and medium from corneal epithelial cells, stromal fibroblasts, and myofibroblasts incubated with plasminogen were separated by SDS-PAGE and electroblotted. Western blots used monoclonal antibodies to kringles 1-3 to detect plasminogen and angiostatins. Angiostatins were isolated and tested for activity in a vascular endothelial cell proliferation inhibition assay. RESULTS: Plasminogen, its mRNA and angiostatins were found in human corneal tissue extracts from the epithelial, stromal, and endothelial layers and from cornea conditioned medium, but not in medium from cultured epithelial cells, stromal fibroblasts, or myofibroblasts. However, cultures of corneal epithelial cells and stromal fibroblasts were able to convert exogenously added plasminogen to angiostatins, whereas cultured myofibroblasts did not. Angiostatins of 38 and 34 kDa were found under all angiostatin generating conditions; however other angiostatins differed in size. Further, the angiostatins isolated from fibroblast culture supernatants inhibited vascular endothelial cell proliferation. CONCLUSIONS: Conversion of plasminogen to angiostatin is cell-type dependent. Because corneal cells generate angiostatins, use of human angiostatins may be a means of treating abnormal corneal neovascularization without the risk of side effects.


Subject(s)
Angiostatins/biosynthesis , Corneal Stroma/metabolism , Epithelium, Corneal/metabolism , Plasminogen/metabolism , Angiostatins/genetics , Angiostatins/pharmacology , Blotting, Western , Cell Culture Techniques , Cell Proliferation/drug effects , Corneal Stroma/cytology , Corneal Stroma/drug effects , Electrophoresis, Polyacrylamide Gel , Endothelium, Vascular/cytology , Epithelium, Corneal/cytology , Epithelium, Corneal/drug effects , Fibroblasts/metabolism , Humans , Organ Culture Techniques , Plasminogen/genetics , Plasminogen/pharmacology , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction
15.
Invest Ophthalmol Vis Sci ; 46(10): 3761-8, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16186360

ABSTRACT

PURPOSE: The purpose of this study was to identify a new Pseudomonas protease and determine its possible role in keratitis. METHODS: Concentrated culture supernatants of the Pseudomonas aeruginosa strains PA103 and ATCC 19660 were analyzed by zymography. P. aeruginosa small protease (PASP) was purified from strain PA103, and modified elastase B (LasB) was purified from strain ATCC 19660. SDS-PAGE and Western blot analysis were performed on purified PASP and modified LasB. PASP was further analyzed by mass spectrometry and amino-terminal sequencing. The Pasp gene was cloned and expressed, affinity-purified in denatured form from inclusion bodies, and refolded by removal of the denaturant. Purified recombinant PASP was analyzed by zymography for protease activity. PASP and heat-inactivated PASP were injected into rabbit corneas, and the corneas were monitored for erosions caused by protease activity. RESULTS: Each strain produced a protease with a molecular mass of 80 kDa on zymograms. LasB antiserum identified the ATCC 19660 protease as modified LasB. Mass spectrometry defined the PA103 protease as having a molecular mass of 18.5 kDa. Amino-terminal sequencing and analysis of the P. aeruginosa genome sequence determined that the PA103 Pasp gene sequence was >99% identical with the PA0423 sequence of strain PAO1. Recombinant PASP was proteolytic, with a zymogram mass of 50 kDa. PASP purified from PA103 produced extensive corneal epithelial erosions, whereas heat-inactivated PASP produced no erosions. CONCLUSIONS: PASP is a protease that has not been previously identified. It causes corneal epithelial erosions, indicating its likely activity as a virulence-promoting factor in Pseudomonas keratitis.


Subject(s)
Cornea/drug effects , Corneal Diseases/chemically induced , Pseudomonas aeruginosa/enzymology , Serine Endopeptidases/pharmacology , Amino Acid Sequence , Animals , Bacterial Proteins/isolation & purification , Bacterial Proteins/pharmacology , Base Sequence , Blotting, Western , Cloning, Molecular , Cornea/pathology , Corneal Diseases/pathology , Electrophoresis, Polyacrylamide Gel , Escherichia coli/genetics , Gene Expression , Metalloendopeptidases/isolation & purification , Metalloendopeptidases/pharmacology , Molecular Sequence Data , Molecular Weight , Rabbits , Recombinant Proteins , Serine Endopeptidases/genetics , Serine Endopeptidases/isolation & purification , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
16.
Biochem J ; 392(Pt 3): 703-12, 2005 Dec 15.
Article in English | MEDLINE | ID: mdl-16097950

ABSTRACT

The overall conformation of plasminogen depends upon the presence of anions and molecules such as AHA (6-aminohexanoic acid) and BZ (benzamidine). The purpose of the present study was to determine the effect of conformation on the initial and secondary cleavages of plasminogen to generate active angiostatins. Plasminogen was digested with the physiologically relevant neutrophil elastase in one of the four Tris/acetate buffers: buffer alone or buffer plus NaCl, AHA or BZ. The initial cleavage of Glu1-plasminogen was much slower in the tight NaCl-induced alpha-conformation, fastest in the intermediate BZ-induced beta-conformation and intermediate both in the control and in the AHA-induced open gamma-conformation. Although the buffer system determined the relative amounts of the initial cleavage products, the same four cleavage sites were utilized under all conditions. A fifth major initial cleavage within the protease domain was observed in the presence of BZ. N-terminal peptide cleavage required for angiostatin formation occurred as either the initial or the secondary cleavage. Angiostatins were generated fastest in the presence of BZ and slowest in the presence of NaCl. Both the initial and secondary cleavages were affected by the modifying agents, indicating that they influence the conformation of both Glu-plasminogen and the initial cleavage products. The angiostatins produced under the different conditions inhibited proliferation of human umbilical-vein endothelial cells. These results suggest that plasminogen conversion into active angiostatins is dependent more on the specific conformation changes induced by the various modifying reagents rather than on the overall openness of the molecule.


Subject(s)
Aminocaproic Acid/pharmacology , Angiostatins/biosynthesis , Benzamidines/pharmacology , Chlorides/pharmacology , Plasminogen/chemistry , Cell Line , Cell Proliferation , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Humans , Neutrophils/enzymology , Pancreatic Elastase/metabolism , Plasminogen/metabolism , Protein Conformation/drug effects
17.
Exp Eye Res ; 78(5): 1007-14, 2004 May.
Article in English | MEDLINE | ID: mdl-15051481

ABSTRACT

The purpose of this work was to establish whether exposing cultured rabbit corneal and lens epithelial cells to ultraviolet radiation equivalent to several hours under the sun would damage the cells. Confluent rabbit corneal epithelial cells were irradiated with broadband UV-A or UV-B, and confluent lens epithelial cells were irradiated with broadband UV-A. The maximum dose of UV-A was 6.3 J cm(-2) and that of UV-B was 0.60 J cm(-2). Damage to corneal epithelial cell was studied using the terminal deoxynucleotidyl transferase mediated dUTP-X nick end labeling (TUNEL) assay and damage to lens epithelial cell was studied using the single cell gel electrophoresis (comet) assay and trypan blue exclusion assay. Lipid peroxidation was assayed using the thiobarbituric acid reaction. Both UV-B and UV-A induced cell death in corneal epithelial cells with different latent periods. UV-A damage included cell death, decreased viability and increased lipid peroxidation of lens epithelial cell. In addition, UV irradiation of the corneal and lens epithelial cells decreased the activity of catalase to thirty to fifty percent of its original value, while the activities of glutathione peroxidase and superoxide dismutase did not decrease within experimental error. Thus, even sub-solar UV radiation can cause irreversible damage to corneal and lens epithelial cells.


Subject(s)
Epithelium, Corneal/radiation effects , Lens Capsule, Crystalline/radiation effects , Ultraviolet Rays , Animals , Catalase/metabolism , Cell Death/radiation effects , Cells, Cultured , Dose-Response Relationship, Radiation , Epithelial Cells/radiation effects , Epithelium, Corneal/metabolism , Lens Capsule, Crystalline/metabolism , Lipid Peroxidation/radiation effects , Rabbits
18.
Microbiology (Reading) ; 149(Pt 8): 2291-2299, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12904569

ABSTRACT

Pseudomonas aeruginosa is an opportunistic bacterial pathogen implicated in a variety of devastating conditions. Its flexibility as a pathogen is attributed to a myriad of virulence factors and regulatory elements that respond to prevailing environmental conditions. ExoS and ExoT are type III secreted effector proteins, regulated by the transcriptional activator ExsA, that can inhibit invasion of epithelial cells by cytotoxic strains of P. aeruginosa. This study sought to understand why invasive strains, which can secrete both ExoS and ExoT, still invade epithelial cells. The results showed that LasA and elastase (LasB), which are regulated by the Las and Rhl quorum-sensing systems, modulated P. aeruginosa invasion. Mutation of lasA and/or lasB reduced P. aeruginosa invasion, which was not fully restored by extracellularly added LasB, P. aeruginosa conditioned medium containing LasA and LasB, or EGTA pretreatment of cells. This indicated that protease effects on invasion involved factors additional to tight junction disruption and subsequent alterations to cell polarity. Upon mutation of lasA and/or lasB, steady-state levels of ExoS and ExoT were increased in culture medium of P. aeruginosa grown under conditions stimulatory for these toxins. The increase in ExoS was significantly correlated with reduced invasion. In vitro experiments showed that purified LasB degraded recombinant ExoS. Taken together, these studies suggest a mechanism by which invasive strains can synthesize inhibitors of invasion, ExoS and ExoT, yet still invade epithelial cells. By this mechanism, LasA and LasB decrease the levels of the toxins directly or indirectly, and thus reduce inhibition of invasion.


Subject(s)
Bacterial Proteins/genetics , Metalloendopeptidases/genetics , Mutation , Pseudomonas aeruginosa/genetics , Pseudomonas aeruginosa/pathogenicity , ADP Ribose Transferases/genetics , ADP Ribose Transferases/metabolism , Animals , Bacterial Proteins/metabolism , Bacterial Toxins/genetics , Bacterial Toxins/metabolism , Caseins/metabolism , Cell Line , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Elastin/metabolism , Endopeptidases/metabolism , Epithelial Cells/microbiology , GTPase-Activating Proteins , In Vitro Techniques , Metalloendopeptidases/metabolism , Pseudomonas aeruginosa/metabolism , Rabbits , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Trans-Activators/genetics , Trans-Activators/metabolism , Virulence/genetics , Virulence/physiology
19.
J Biol Chem ; 278(34): 31796-806, 2003 Aug 22.
Article in English | MEDLINE | ID: mdl-12799381

ABSTRACT

Maspin, an ov-serpin, inhibits tumor invasion and induces cell adhesion to extracellular matrix molecules. Here, we use maspin/ovalbumin chimeric proteins and the maspin reactive site loop (RSL) peptide to characterize the role of the RSL in maspin-mediated functions. Replacement of the RSL plus the C-terminal region or the RSL alone of maspin with that of ovalbumin resulted in the loss of the stimulatory effect on adhesion of corneal stromal cells to type I collagen, fibronectin, and laminin and of mammary carcinoma MDA-MB-231 cells to fibronectin. Maspin with ovalbumin as the C-terminal region retained activity, suggesting the maspin C-terminal polypeptide is not required. An R340Q mutant retained full maspin activity; however, an R340A mutant lost activity. This indicates the arginine side chain at the putative P1 site forms a hydrogen bond and not an ionic bond. The RSL peptide (P10-P5', amino acids 330-345) alone induced cell-matrix adhesion of mammary carcinoma cells and corneal stromal cells and inhibited invasion of the carcinoma cells. Substitution of the RSL of ovalbumin with that of maspin converted inactive ovalbumin into a fully active molecule. Maspin bound specifically to the surface of the mammary carcinoma cells with a kd of 367 +/- 67 nM and 32.0 +/- 2.2 x 10(6) binding sites/cell. The maspin RSL peptide inhibited binding, suggesting the RSL is involved in maspin binding to cells. Sufficiency of the maspin RSL for activity suggests the mechanism by which maspin regulates cell-matrix adhesion and tumor cell invasion does not involve the serpin mechanism of protease inhibition.


Subject(s)
Albumins/metabolism , Cell Adhesion , Proteins/metabolism , Serpins/metabolism , Amino Acid Sequence , Base Sequence , DNA Primers , Genes, Tumor Suppressor , Humans , Hydrogen Bonding , Models, Molecular , Molecular Sequence Data , Protein Conformation , Proteins/chemistry , Serpins/chemistry , Tumor Cells, Cultured
20.
Biotechniques ; 33(6): 1296-300, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12503315

ABSTRACT

Expression of recombinant proteins using a secretion system can minimize co-purification of contaminating host proteins. Production of His-tagged recombinant proteins in the yeast alpha-factor secretion system has previously required a fermenter system to control the growth conditions such as pH of the yeast culture. We describe an inexpensive non-fermenter system for the production of secreted recombinant His-tagged proteins in Saccharomyces cerevisiae that uses a buffered low peptone YP glycerol medium, which does not interfere with immobilized metal affinity chromatography. Maspin, a tumor suppressor serpin, was expressed as a secreted N-terminal His/FLAG-tagged protein. Purification of the soluble active recombinant protein only requires centrifugation, concentration by ultrafiltration, and Ni2+ affinity chromatography. Purified protein yields of this system are 3-5 mg/L culture medium.


Subject(s)
Cloning, Molecular/methods , Histidine/chemistry , Proteins/isolation & purification , Saccharomyces cerevisiae/metabolism , Serpins/isolation & purification , Buffers , Centrifugation , Chromatography, Affinity/methods , Culture Media , Genes, Tumor Suppressor , Humans , Hydrogen-Ion Concentration , Nickel , Nitrilotriacetic Acid , Oligopeptides , Peptides , Protein Biosynthesis , Proteins/genetics , Proteins/metabolism , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/isolation & purification , Recombinant Fusion Proteins/metabolism , Saccharomyces cerevisiae/growth & development , Serpins/biosynthesis , Serpins/genetics , Serpins/metabolism , Ultrafiltration
SELECTION OF CITATIONS
SEARCH DETAIL
...